Cargando…

Physiologically Based Pharmacokinetic Modelling with Dynamic PET Data to Study the In Vivo Effects of Transporter Inhibition on Hepatobiliary Clearance in Mice

Physiologically based pharmacokinetic modelling (PBPK) is a powerful tool to predict in vivo pharmacokinetics based on physiological parameters and data from in vivo studies and in vitro assays. In vivo PBPK modelling in laboratory animals by noninvasive imaging could help to improve the in vivo-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taddio, Marco F., Mu, Linjing, Keller, Claudia, Schibli, Roger, Krämer, Stefanie D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008768/ https://www.ncbi.nlm.nih.gov/pubmed/29967572 http://dx.doi.org/10.1155/2018/5849047

Ejemplares similares

In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET
por: Taddio, Marco F., et al.
Publicado: (2020)

[(11)C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [(18)F]LMI1195 uptake is NET-independent
por: Mu, Linjing, et al.
Publicado: (2020)

In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
por: Ni, Ruiqing, et al.
Publicado: (2021)

Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
por: Mu, Linjing, et al.
Publicado: (2014)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
por: Jie, Caitlin V. M. L., et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging
por: Haider, Ahmed, et al.
Publicado: (2016)

FDG kinetic modeling in small rodent brain PET: optimization of data acquisition and analysis
por: Alf, Malte F, et al.
Publicado: (2013)

Improved Syntheses of the mGlu(5) Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling
por: Mu, Boshuai, et al.
Publicado: (2018)

Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
por: Amice, Basile, et al.
Publicado: (2021)

Radiation dosimetry of [(18)F]-PSS232—a PET radioligand for imaging mGlu5 receptors in humans
por: Sah, Bert-Ram, et al.
Publicado: (2019)

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
por: Trachsel, Belinda, et al.
Publicado: (2023)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

Hepatobiliary
Publicado: (2013)

Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments
por: Pastor, Catherine M., et al.
Publicado: (2021)

A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically‐Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate
por: Wu, Qier, et al.
Publicado: (2019)

Role of serum IgA. Hepatobiliary transport of circulating antigen
Publicado: (1981)

P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses
por: Ho, Harvey, et al.
Publicado: (2023)

Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [(18)F]PSS232 in the Rat Brain
por: Müller Herde, Adrienne, et al.
Publicado: (2018)

Improving Hepatobiliary Imaging as a Physiologic Test with Superior Clinical Outcomes
por: Gayed, Isis W., et al.
Publicado: (2020)

The Physiology of Insulin Clearance
por: Bergman, Richard N., et al.
Publicado: (2022)

Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach
por: Alqahtani, Faleh, et al.
Publicado: (2023)

Hepatobiliary tuberculosis
por: Chaudhary, Poras
Publicado: (2014)

Hepatobiliary Cystadenocarcinoma
por: Wilkinson, Neal
Publicado: (2012)

Hepatobiliary Schistosomiasis
por: Shaker, Yehia, et al.
Publicado: (2014)

Hepatobiliary Disease
por: DAILY, JOHANNA P., et al.
Publicado: (2006)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Hepatobiliary Brucellosis: Brucella Bacteremia Presenting with Refractory Hepatobiliary Infection
por: El Hallak, Dania, et al.
Publicado: (2023)

Dynamic PET/CT with the Hepatobiliary Tracer [68Ga]Ga-Tmos-DAZA for Characterization of a Hepatic Tumor
por: Freesmeyer, Martin, et al.
Publicado: (2021)

Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System
por: Jazaeri, Farahnaz, et al.
Publicado: (2021)

An Update to Hepatobiliary Stents
por: Moy, Brian T., et al.
Publicado: (2015)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

Hepatobiliary and pancreatic ascariasis
por: Khuroo, Mohammad S, et al.
Publicado: (2016)

Update on Hepatobiliary Plasticity
por: Kim, Minwook, et al.
Publicado: (2023)

Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo
por: Zhang, Haifeng, et al.
Publicado: (2015)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
por: Kim, Min-Chang, et al.
Publicado: (2022)

Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling
por: Yeung, Cindy H. T., et al.
Publicado: (2023)

Evaluating Hepatobiliary Transport with (18)F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and In Vitro and In Vivo Performance
por: De Lombaerde, Stef, et al.
Publicado: (2018)

Predicting human pharmacokinetics from preclinical data: clearance
por: Yim, Dong-Seok, et al.
Publicado: (2021)

Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011)

Stem Cells in Hepatobiliary Diseases
por: Aejaz, HM, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_cm10hotmp03mjbmqsqeuuqgmau